PHS
ESRX

PFM Health Sciences’s Express Scripts Holding Company ESRX Stock Holding History

PFM Health Sciences’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-278,846
Closed -$23.6M – 107
2014
Q4 		$23.6M Buy
+278,846
New +$21.8M 0.55% 54
2013
Q3 		– Sell
-196,696
Closed -$12.1M – 94
2013
Q2 		$12.1M Buy
+196,696
New +$11.8M 0.25% 58

Other funds holding ESRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

PFM Health Sciences's ESRX Position: Q1 2015 in Review

PFM Health Sciences sold out of Express Scripts Holding Company (ESRX) in Q1 2015, closing a stake of 278,846 shares — an estimated $23.6M sold.

PFM Health Sciences first reported a position in ESRX in Q2 2013 and held it in 2 quarters. The position peaked at $23.6M in Q4 2014. 1,226 funds tracked by Wall St. Rank hold ESRX as of Q1 2015.

  • PFM Health Sciences reported no remaining Express Scripts Holding Company position as of Q1 2015 after selling out during the quarter.
  • PFM Health Sciences sold 278,846 Express Scripts Holding Company shares in Q1 2015, an estimated $23.6M.
  • PFM Health Sciences first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 2 quarters.
  • PFM Health Sciences's Express Scripts Holding Company position peaked at $23.6M in Q4 2014.
  • 1,226 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q1 2015.

Based on PFM Health Sciences's 13F filing for Q1 2015, filed 15 May 2015.